Skip to main content

Articles

Page 212 of 335

  1. Irisin is a recently discovered myokine, involved in the browning of white adipose tissue. To date, its function has been mainly associated with energy homeostasis and metabolism, and it has been proposed as a...

    Authors: Xeni Provatopoulou, Georgia P. Georgiou, Eleni Kalogera, Vasileios Kalles, Maira A. Matiatou, Ioannis Papapanagiotou, Alexandros Sagkriotis, George C. Zografos and Antonia Gounaris
    Citation: BMC Cancer 2015 15:898
  2. Disseminated tumor cells (DTCs) can be detected using ultrasensitive immunocytochemical assays and their presence in the bone marrow can predict the subsequent occurrence of overt metastasis formation and meta...

    Authors: Stefan Werner, Hauke Stamm, Mutiha Pandjaitan, Dirk Kemming, Benedikt Brors, Klaus Pantel and Harriet Wikman
    Citation: BMC Cancer 2015 15:896
  3. Chondrosarcoma is characterized for its lack of response to conventional cytotoxic chemotherapy, propensity for developing lung metastases, and low rates of survival. Research within the field of development a...

    Authors: Birgit Lohberger, Andreas Leithner, Nicole Stuendl, Heike Kaltenegger, Werner Kullich and Bibiane Steinecker-Frohnwieser
    Citation: BMC Cancer 2015 15:891
  4. To summarize data on long-term ipsilateral local recurrence (LR) and breast cancer death rate (BCDR) for patients with ductal carcinoma in situ (DCIS) who received different treatments.

    Authors: Kirsty E. Stuart, Nehmat Houssami, Richard Taylor, Andrew Hayen and John Boyages
    Citation: BMC Cancer 2015 15:890
  5. Ovarian cancer is a possibly lethal gynecological malignancy and this study utilized phage display technology to screen and identify peptides that specifically bind to ovarian cancer cells and explored the eff...

    Authors: Cong Zhou, Jiali Kang, Xiaoxia Wang, Wei Wei and Wenyan Jiang
    Citation: BMC Cancer 2015 15:889
  6. In humans, sex-determining region-Y (SRY) related high-mobility-group box 4 (SOX4) is linked to development and tumorigenesis. SOX4 is over-expressed in several cancers and has prognostic significance. This st...

    Authors: Tae Mi Yoon, Sun-Ae Kim, Wan Seok Cho, Dong Hoon Lee, Joon Kyoo Lee, Young-Lan Park, Kyung-Hwa Lee, Jae Hyuk Lee, Sun-Seog Kweon, Ik-Joo Chung, Sang Chul Lim and Young-Eun Joo
    Citation: BMC Cancer 2015 15:888
  7. Approximately 10–15 % of gastrointestinal stromal tumors (GISTs) lack gain of function mutations in the KIT and platelet-derived growth factor receptor alpha (PDGFRA) genes. An alternate mechanism of oncogenesis ...

    Authors: Martin G. Belinsky, Lori Rink, Kathy Q. Cai, Stephen J. Capuzzi, Yen Hoang, Jeremy Chien, Andrew K. Godwin and Margaret von Mehren
    Citation: BMC Cancer 2015 15:887
  8. USP18 (ubiquitin-specific protease 18) removes ubiquitin-like modifier interferon stimulated gene 15 (ISG15) from conjugated proteins. USP18 null mice in a FVB/N background develop tumors as early as 2 months ...

    Authors: Fadzai Chinyengetere, David J. Sekula, Yun Lu, Andrew J. Giustini, Aarti Sanglikar, Masanori Kawakami, Tian Ma, Sandra S. Burkett, Burton L. Eisenberg, Wendy A. Wells, Paul J. Hoopes, Elizabeth G. Demicco, Alexander J Lazar, Keila E. Torres, Vincent Memoli, Sarah J. Freemantle…
    Citation: BMC Cancer 2015 15:886
  9. Cyclin-dependent protein kinase-5 (CDK5) is an unusual member of the CDK family as it is not cell cycle regulated. However many of its substrates have roles in cell growth and oncogenesis, raising the possibil...

    Authors: Nicola J. Grant, Philip J. Coates, Yvonne L. Woods, Susan E. Bray, Nicholas A. Morrice, C. James Hastie, Douglas J. Lamont, Francis A. Carey and Calum Sutherland
    Citation: BMC Cancer 2015 15:885
  10. Mucinous adenocarcinoma (MAC) represents 6-19 % of all colorectal carcinoma. It is associated with poorer response to chemotherapy and chemoradiotherapy.

    Authors: Karolina Vernmark, Maria Albertsson, Bergthor Björnsson, Thomas Gasslander, Per Sandström, Xiao-Feng Sun and Annika Holmqvist
    Citation: BMC Cancer 2015 15:884
  11. The development of androgen resistance is a major limitation to androgen deprivation treatment in prostate cancer. We have developed an in vitro model of androgen-resistance to characterise molecular changes occu...

    Authors: Sujitra Detchokul, Aparna Elangovan, Edmund J. Crampin, Melissa J. Davis and Albert G. Frauman
    Citation: BMC Cancer 2015 15:883
  12. Recurrence of colorectal cancer (CRC) may arise due to the persistence of drug-resistant and cancer-initiating cells that survive exposure to chemotherapy. Proteins responsible for this recurrence include the ...

    Authors: Murray J. Cutler, Erica L. Lowthers, Cynthia L. Richard, Dagmar M. Hajducek, Paul A. Spagnuolo and Jonathan Blay
    Citation: BMC Cancer 2015 15:882
  13. We aimed to estimate the effect of alcohol consumption on breast cancer risk and to test whether overweight and obesity modifies this association.

    Authors: Aesun Shin, Sven Sandin, Marie Lof, Karen L. Margolis, Kyeezu Kim, Elisabeth Couto, Hans Olov Adami and Elisabete Weiderpass
    Citation: BMC Cancer 2015 15:881
  14. Aberrant sialylated carbohydrate synthesis is frequently noted in various cancers. Sialyltransferase ST3GAL-1, which adds a sialic acid in an α-2,3 linkage to Gal β1,3 GalNAc, preforms an important role in mod...

    Authors: Qi Bai, Li Liu, Yu Xia, Qilai Long, Jiajun Wang, Jiejie Xu and Jianming Guo
    Citation: BMC Cancer 2015 15:880
  15. Adult Langerhans cell histiocytosis (LCH) is an orphan disease. Chemotherapy is usually reserved to patients presenting with single system multifocal (SS-m) or multisystem (MS) disease but due to the lack of r...

    Authors: Enrico Derenzini, Vittorio Stefoni, Cinzia Pellegrini, Letizia Gandolfi, Alessandro Broccoli, Beatrice Casadei, Federica Quirini, Lisa Argnani, Lorenzo Tonialini and Pier Luigi Zinzani
    Citation: BMC Cancer 2015 15:879
  16. Despite demonstrated efficacy, acceptance of selective estrogen receptor modulators (SERMs), such as tamoxifen, for breast cancer risk reduction remains low. Delivering SERMs via local transdermal therapy (LTT...

    Authors: Lindsey C. Karavites, Subhashini Allu, Seema A. Khan and Karen Kaiser
    Citation: BMC Cancer 2015 15:878
  17. CHEK2*1100delC is a moderate-risk breast cancer susceptibility allele with a high prevalence in the Netherlands. We performed copy number and gene expression profiling to investigate whether CHEK2*1100delC breast...

    Authors: Maarten P. G. Massink, Irsan E. Kooi, John W. M. Martens, Quinten Waisfisz and Hanne Meijers-Heijboer
    Citation: BMC Cancer 2015 15:877
  18. Little is known about sex-specific trends in lung cancer mortality and years of potential life lost (YPLL) attributable to lung cancer over more than five decades. The aim of the present study was to describe ...

    Authors: Ulrich John and Monika Hanke
    Citation: BMC Cancer 2015 15:876
  19. Evidence-based guidelines concerning the older head and neck cancer (HNCA) patient are lacking. Accurate patient selection for optimal care management is therefore challenging. We examined if geriatric assessm...

    Authors: Lies Pottel, Michelle Lycke, Tom Boterberg, Hans Pottel, Laurence Goethals, Fréderic Duprez, Sylvie Rottey, Yolande Lievens, Nele Van Den Noortgate, Kurt Geldhof, Véronique Buyse, Khalil Kargar-Samani, Véronique Ghekiere and Philip R. Debruyne
    Citation: BMC Cancer 2015 15:875
  20. The enhancer of zeste-homolog 2 (EZH2) is involved in cancer development through gene silencing by trimethylation of lysine 27 of histone 3 (H3K27me3). The C/C genotype for the EZH2 rs3757441 single-nucleotide po...

    Authors: Lorenzo Fornaro, Pinuccia Faviana, Veronica De Gregorio, Caterina Vivaldi, Elisa Paolicchi, Gianluca Masi, Fotios Loupakis, Elisa Sensi, Cristiana Lupi, Gabriella Fontanini, Yuzhuo Wang, Romano Danesi, Alfredo Falcone and Francesco Crea
    Citation: BMC Cancer 2015 15:874
  21. With the advent of new and more efficient anti-androgen drugs targeting androgen receptor (AR) in breast cancer (BC) is becoming an increasingly important area of investigation. This would potentially be most ...

    Authors: André Grogg, Mafalda Trippel, Katrin Pfaltz, Claudia Lädrach, Raoul A. Droeser, Nikola Cihoric, Bodour Salhia, Martin Zweifel and Coya Tapia
    Citation: BMC Cancer 2015 15:872
  22. Synchronous multifocal tumours are commonly observed in urothelial carcinomas of the bladder. The origin of these physically independent tumours has been proposed to occur by either intraluminal migration (clo...

    Authors: Ömer Acar, Ezgi Özkurt, Gulfem Demir, Hilal Saraç, Can Alkan, Tarık Esen, Mehmet Somel and Nathan A. Lack
    Citation: BMC Cancer 2015 15:871
  23. Colon cancer is the third most commonly diagnosed cancer and the second leading cause of cancer mortality worldwide. Chalcone and its derivatives are reported to exhibit anti-cancer effects in several cancer c...

    Authors: Shanmei Xu, Minxiao Chen, Wenbo Chen, Junguo Hui, Jiansong Ji, Shuping Hu, Jianmin Zhou, Yi Wang and Guang Liang
    Citation: BMC Cancer 2015 15:870
  24. Tumor-suppressor genes are inactivated by methylation in several cancers including acute myeloid leukemia (AML). Src homology-2 (SH2)-containing protein-tyrosine phosphatase 1 (SHP-1) is a negative regulator of t...

    Authors: Hamid Ali Nagi Al-Jamal, Siti Asmaa Mat Jusoh, Rosline Hassan and Muhammad Farid Johan
    Citation: BMC Cancer 2015 15:869
  25. Definitive, percutaneous irradiation of the prostate and the pelvic lymph nodes in high-risk prostate cancer is the alternative to prostatectomy plus lymphadenectomy. To date, the role of whole pelvis radiothe...

    Authors: Gregor Habl, Sonja Katayama, Matthias Uhl, Kerstin A. Kessel, Lutz Edler, Juergen Debus, Klaus Herfarth and Florian Sterzing
    Citation: BMC Cancer 2015 15:868
  26. Hypoxia inducible factor-1 alpha (HIF-1α) is thought to play a role in melanoma carcinogenesis. Posttranslational regulation of HIF-1α is dependent on Prolyl hydroxylase (PHD 1–3) and Factor Inhibiting HIF (FI...

    Authors: Sarah L. Miles, Adam P. Fischer, Sandeep J. Joshi and Richard M. Niles
    Citation: BMC Cancer 2015 15:867
  27. Prostate cancer is the most commonly diagnosed malignancy among men. The Discovery of new agents for the treatment of prostate cancer is urgently needed. Compound WZ35, a novel analog of the natural product cu...

    Authors: Xiuhua Zhang, Minxiao Chen, Peng Zou, Karvannan Kanchana, Qiaoyou Weng, Wenbo Chen, Peng Zhong, Jiansong Ji, Huiping Zhou, Langchong He and Guang Liang
    Citation: BMC Cancer 2015 15:866
  28. The association between body mass index (BMI) at the time of breast cancer diagnosis and the prognosis of breast cancer patients remains controversial. Furthermore, the association between BMI and prognosis wi...

    Authors: Ye Won Jeon, Su Hwan Kang, Min Ho Park, Woosung Lim, Se Heun Cho and Young Jin Suh
    Citation: BMC Cancer 2015 15:865
  29. Human primary myeloma (MM) cells do not survive in culture; current in vitro and in vivo systems for growing these cells are limited to coculture with a specific bone marrow (BM) cell type or growth in an immu...

    Authors: Rakesh Bam, Sharmin Khan, Wen Ling, Shelton S. Randal, Xin Li, Bart Barlogie, Ricky Edmondson and Shmuel Yaccoby
    Citation: BMC Cancer 2015 15:864
  30. Metastasis to the pituitary gland is extremely rare and is often detected incidentally by symptoms associated with endocrine dysfunction. Breast and lung cancer are the most common primary metastasizing to pit...

    Authors: Tomoko Tanaka, Katsushi Hiramatsu, Takuto Nosaka, Yasushi Saito, Tatsushi Naito, Kazuto Takahashi, Kazuya Ofuji, Hidetaka Matsuda, Masahiro Ohtani, Tomoyuki Nemoto, Hiroyuki Suto, Tatsuya Yamamoto, Hirohiko Kimura and Yasunari Nakamoto
    Citation: BMC Cancer 2015 15:863
  31. Argonaute 2 (AGO2), a central component of RNA-induced silencing complex, plays critical roles in cancer. We examined whether the single nucleotide polymorphisms (SNPs) of AGO2 were related to the risk of nasopha...

    Authors: Peiyao Li, Jinfeng Meng, Yun Zhai, Hongxing Zhang, Lixia Yu, Zhifu Wang, Xiaoai Zhang, Pengbo Cao, Xi Chen, Yuqing Han, Yang Zhang, Huipeng Chen, Yan Ling, Yuxia Li, Ying Cui, Jin-Xin Bei…
    Citation: BMC Cancer 2015 15:862
  32. Squamous cell carcinoma of the head and neck (SCCHN) remains a prevalent and devastating disease. Recently, there has been an increase in SCCHN cases that are associated with high-risk human papillomavirus (HP...

    Authors: Bhavana V. Chapman, Abigail I. Wald, Parvez Akhtar, Ana C. Munko, Jingjing Xu, Sandra P. Gibson, Jennifer R. Grandis, Robert L. Ferris and Saleem A. Khan
    Citation: BMC Cancer 2015 15:861
  33. Persistent high-risk human papillomavirus (HPV) infection is correlated with an increased risk of developing intraepithelial lesion or malignancy (NILM). The aims of the current study is to establish a method ...

    Authors: Zhengrong Sun, Rong Zhang, Zhonghua Liu, Chao Liu, Xiulin Li, Weiqiang Zhou, Lianxia Yang, Qiang Ruan and Xu Zhang
    Citation: BMC Cancer 2015 15:860
  34. Extramural tumor deposits (TDs) and extracapsular lymph node involvement (ECLNI) are considered to be poor prognostic factors in patients with T3–4, N0–2, M0 colorectal cancer (CRC). Although TDs are known to ...

    Authors: Tomoki Yamano, Shuho Semba, Masafumi Noda, Mie Yoshimura, Masayoshi Kobayashi, Michiko Hamanaka, Naohito Beppu, Aya Yano, Kiyoshi Tsukamoto, Nagahide Matsubara and Naohiro Tomita
    Citation: BMC Cancer 2015 15:859
  35. The incidence of thyroid cancer in Korea has increased by about 25 % every year for the past 10 years. This increase is largely due to a rising incidence in papillary thyroid cancer, which is associated with a...

    Authors: Sang Hee Park, Bomyee Lee, Sangeun Lee, Eunji Choi, Eun-Bi Choi, Jisu Yoo, Jae Kwan Jun and Kui Son Choi
    Citation: BMC Cancer 2015 15:858
  36. Malignant pleural mesothelioma (MPM) is a rare disease with poor prognosis in spite of significant improvement in survival, due to new chemotherapy regimens. We describe here patients’ profiles and management ...

    Authors: C. Raynaud, L. Greillier, J. Mazieres, I. Monnet, B. Mastroianni, G. Robinet, G. Fraboulet, A. Dixmier, H. Berard, R. Lamy, J. Letreut, H. Lena, G. Oliviero, S. Botta, A. Vergnenegre, I. Borget…
    Citation: BMC Cancer 2015 15:857
  37. The prognostic value of histone γ-H2AX and 53BP1 proteins to predict the radiotherapy (RT) outcome of patients with rectal carcinoma (RC) was evaluated in a prospective study. High expression of the constituti...

    Authors: Cholpon S. Djuzenova, Marcus Zimmermann, Astrid Katzer, Vanessa Fiedler, Luitpold V. Distel, Martin Gasser, Anna-Maria Waaga-Gasser, Michael Flentje and Bülent Polat
    Citation: BMC Cancer 2015 15:856
  38. Nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in NAD+ biosynthesis from nicotinamide, is one of the major factors regulating cancer cells metabolism and is considered a promising target...

    Authors: Chiara Zucal, Vito G. D’Agostino, Antonio Casini, Barbara Mantelli, Natthakan Thongon, Debora Soncini, Irene Caffa, Michele Cea, Alberto Ballestrero, Alessandro Quattrone, Stefano Indraccolo, Alessio Nencioni and Alessandro Provenzani
    Citation: BMC Cancer 2015 15:855
  39. The objective of this study is to explore the off-label use of targeted therapies (TTs) for patients with osteosarcoma registered within the French Sarcoma Group – Bone Tumor Study Group (GSF-GETO) national re...

    Authors: Mathilde Penel-Page, Isabelle Ray-Coquard, Julie Larcade, Magali Girodet, Laure Bouclier, Muriel Rogasik, Nadège Corradini, Natacha Entz-Werle, Laurence Brugieres, Julien Domont, Cyril Lervat, Sophie Piperno-Neumann, Helène Pacquement, Jacques-Olivier Bay, Jean-Claude Gentet, Antoine Thyss…
    Citation: BMC Cancer 2015 15:854
  40. The aim of this study was to develop a scoring system for prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression (MSCC) from non-small cell lung cancer (...

    Authors: Mingxing Lei, Yaosheng Liu, Chuanghao Tang, Shaoxing Yang, Shubin Liu and Shiguo Zhou
    Citation: BMC Cancer 2015 15:853
  41. Type 2 diabetes mellitus (T2DM) has been suggested to increase the risk of cancers. The aim of this study was to investigate the risk of common cancers in Chinese patients with T2DM.

    Authors: Hui-Lin Xu, Hong Fang, Wang-Hong Xu, Guo-You Qin, Yu-Jie Yan, Bao-Dong Yao, Nai-Qing Zhao, Yi-Nan Liu, Fen Zhang, Wei-Xi Li, Na Wang, Jie Zhou, Jin-Ling Zhang, Li-Yun Zhao, Lun-Qiang Li and Yan-Ping Zhao
    Citation: BMC Cancer 2015 15:852
  42. The use of flaps in vulvar cancer-related reconstruction has been increasing, but few studies have evaluated the outcome and quality of life of patients after this surgery. The purpose of this study was to eva...

    Authors: Wei Zhang, Ang Zeng, Jiaxin Yang, Dongyan Cao, Xiaodong He, Xiaojun Wang, Yan You, Jie Chen, Jinghe Lang and Keng Shen
    Citation: BMC Cancer 2015 15:851
  43. Comorbidity increases overall mortality in patients diagnosed with hematological malignancies. The impact of comorbidity on cancer-specific mortality, taking competing risks into account, has not been evaluated.

    Authors: Mohammad Mohammadi, Yang Cao, Ingrid Glimelius, Matteo Bottai, Sandra Eloranta and Karin E. Smedby
    Citation: BMC Cancer 2015 15:850
  44. Cervical cancer (CC) is -second to breast cancer- a dominant cause of gynecological cancer-related deaths worldwide. CC tumor biopsies and blood samples are of easy access and vital for the development of futu...

    Authors: Charlotte Ngo, Sanne Samuels, Ksenia Bagrintseva, Andrea Slocker, Philippe Hupé, Gemma Kenter, Marina Popovic, Nina Samet, Patricia Tresca, Heiko von der Leyen, Eric Deutsch, Roman Rouzier, Lisa Belin, Maud Kamal and Suzy Scholl
    Citation: BMC Cancer 2015 15:842
  45. Accumulation of tumor-infiltrating mast cells (MCs) predicts poor survival in several cancers after resection. However, its effect on the prognosis of patients with colorectal liver metastases (CRLM) is not kn...

    Authors: Shinsuke Suzuki, Yasushi Ichikawa, Kazuya Nakagawa, Takafumi Kumamoto, Ryutaro Mori, Ryusei Matsuyama, Kazuhisa Takeda, Mitsuyoshi Ota, Kuniya Tanaka, Tomohiko Tamura and Itaru Endo
    Citation: BMC Cancer 2015 15:840

Featured videos

View featured videos from across the BMC-series journals